Tenaya Therapeutics Stock

tenayatherapeutics.comHealthcareFounded: 2016Funding to Date: $142MM

Tenaya Therapeutics is a biopharmaceutical company focused on addressing heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle and that leverage cutting-edge research in cardiac development and regeneration.

Register for Details

For more details on financing and valuation for Tenaya Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Tenaya Therapeutics.

Register Today

Team

Management Team

JJ Kang Ph.D
President & Board Member
Benoit Bruneau Ph.D
Scientific Co-Founder
Sheng Ding Ph.D
Co-Founder
Timothy Hoey Ph.D
Chief Scientific Officer
Bruce Conklin MD
Scientific Co-Founder
Whittemore Tingley Ph.D
Chief Medical Officer
Faraz Ali
Board Member & Chief Executive Officer
Deepak Srivastava MD
Scientific Co-Founder & Board Member
Saptarsi Haldar MD
Scientific Co-Founder
Eric Olson Ph.D
Scientific Co-Founder

Board Members

David Goeddel Ph.D
The Column Group
Jin-Long Chen Ph.D
Deepak Srivastava MD
Faraz Ali
JJ Kang Ph.D
Anthony Philippakis MD
GV
Eli Casdin
Casdin Capital
Robert Sanders Williams MD

Other companies like Tenaya Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector
 
 

News

Tenaya Therapeutics, a company aiming to discover and develop curative therapies that target the underlying causes of heart disease, has raised $92 million.
/PRNewswire/ -- Tenaya Therapeutics, Inc., a company with a mission to discover, develop, and deliver curative therapies that target the underlying causes of...